top of page

Research Note AD State of Play

250,00€Price

Includes a minimum of three updates and approximately one hour of consultancy by phone. This research note provides a comprehensive overview of the state of play of treatment for Alzheimer's disease. The companies that are the focus of this research are BioVie, INmune Bio, Cassava Sciences and Coya Therapeutics. .

© 2025 Carl Kestens

The publications on this website express my ideas, and should not be taken as investment advice. I am the sole author of them, and am not receiving any compensation for them.

bottom of page